Crossref
Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study
Beyoglu Eye Journal · 2017
DOI: 10.14744/bej.2017.13007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Beyoglu Eye Journal, 2017. Verfasst von Abdullah Özkaya.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Özkaya, A. (2017). Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study. Beyoglu Eye Journal. https://doi.org/10.14744/bej.2017.13007
Vancouver
Özkaya A. Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study. Beyoglu Eye Journal. 2017. doi:10.14744/bej.2017.13007
BibTeX
@article{zkaya2017,
author = {Özkaya, Abdullah},
title = {Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study},
journal = {Beyoglu Eye Journal},
year = {2017},
doi = {10.14744/bej.2017.13007}
}
EUVIMED